 | • レポートコード：D005-00219 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、大腸がんの世界市場を広く調査・分析し、今後の市場展望をまとめております。大腸がんの種類別市場規模（肉眼検査、顕微鏡検査、免疫化学、病期分類、腫瘍出芽）、用途別市場規模（病院・クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、Mologen、Vaccinogen、Debiopharm、Spectrum Pharmaceuticals、Merck Kgaa、Bayer Healthcare、Keryx、Aeterna Zentaris、Amgen ・地域別グローバル市場分析 2015年-2020年 ・大腸がんの北米市場（アメリカ、カナダ、メキシコ） ・大腸がんのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・大腸がんのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・大腸がんの南米市場（ブラジル、アルゼンチン） ・大腸がんの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：肉眼検査、顕微鏡検査、免疫化学、病期分類、腫瘍出芽 ・用途別分析：病院・クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Colorectal Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.1% in the forecast period of 2020 to 2025 and will expected to reach USD 9118.8 million by 2025, from USD 8386.1 million in 2019.
The Colorectal Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Colorectal Cancer market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Colorectal Cancer market has been segmented into:
Macroscopy
Microscopy
Immunochemistry
Staging
Tumor Budding
By Application, Colorectal Cancer has been segmented into:
Hospitals and Clicnics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Colorectal Cancer market presented in the report. This section sheds light on the sales growth of different regional and country-level Colorectal Cancer markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Colorectal Cancer market.
The report offers in-depth assessment of the growth and other aspects of the Colorectal Cancer market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Colorectal Cancer Market Share Analysis
Colorectal Cancer competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Colorectal Cancer sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Colorectal Cancer sales, revenue and market share for each player covered in this report.
The major players covered in Colorectal Cancer are:
Roche
Mologen
Vaccinogen
Debiopharm
Spectrum Pharmaceuticals
Merck Kgaa
Bayer Healthcare
Keryx
Aeterna Zentaris
Amgen
Table of Contents
1 Colorectal Cancer Market Overview
1.1 Product Overview and Scope of Colorectal Cancer
1.2 Classification of Colorectal Cancer by Type
1.2.1 Global Colorectal Cancer Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Colorectal Cancer Revenue Market Share by Type in 2019
1.2.3 Macroscopy
1.2.4 Microscopy
1.2.5 Immunochemistry
1.2.6 Staging
1.2.7 Tumor Budding
1.3 Global Colorectal Cancer Market by Application
1.3.1 Overview: Global Colorectal Cancer Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals and Clicnics
1.3.3 Others
1.4 Global Colorectal Cancer Market by Regions
1.4.1 Global Colorectal Cancer Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Colorectal Cancer (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Colorectal Cancer Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Colorectal Cancer Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Colorectal Cancer Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Colorectal Cancer Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Colorectal Cancer Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Colorectal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mologen
2.2.1 Mologen Details
2.2.2 Mologen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mologen SWOT Analysis
2.2.4 Mologen Product and Services
2.2.5 Mologen Colorectal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.3 Vaccinogen
2.3.1 Vaccinogen Details
2.3.2 Vaccinogen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Vaccinogen SWOT Analysis
2.3.4 Vaccinogen Product and Services
2.3.5 Vaccinogen Colorectal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.4 Debiopharm
2.4.1 Debiopharm Details
2.4.2 Debiopharm Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Debiopharm SWOT Analysis
2.4.4 Debiopharm Product and Services
2.4.5 Debiopharm Colorectal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.5 Spectrum Pharmaceuticals
2.5.1 Spectrum Pharmaceuticals Details
2.5.2 Spectrum Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Spectrum Pharmaceuticals SWOT Analysis
2.5.4 Spectrum Pharmaceuticals Product and Services
2.5.5 Spectrum Pharmaceuticals Colorectal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck Kgaa
2.6.1 Merck Kgaa Details
2.6.2 Merck Kgaa Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck Kgaa SWOT Analysis
2.6.4 Merck Kgaa Product and Services
2.6.5 Merck Kgaa Colorectal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bayer Healthcare
2.7.1 Bayer Healthcare Details
2.7.2 Bayer Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bayer Healthcare SWOT Analysis
2.7.4 Bayer Healthcare Product and Services
2.7.5 Bayer Healthcare Colorectal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.8 Keryx
2.8.1 Keryx Details
2.8.2 Keryx Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Keryx SWOT Analysis
2.8.4 Keryx Product and Services
2.8.5 Keryx Colorectal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.9 Aeterna Zentaris
2.9.1 Aeterna Zentaris Details
2.9.2 Aeterna Zentaris Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Aeterna Zentaris SWOT Analysis
2.9.4 Aeterna Zentaris Product and Services
2.9.5 Aeterna Zentaris Colorectal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Amgen SWOT Analysis
2.10.4 Amgen Product and Services
2.10.5 Amgen Colorectal Cancer Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Colorectal Cancer Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Colorectal Cancer Players Market Share
3.2.2 Top 10 Colorectal Cancer Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Colorectal Cancer Revenue and Market Share by Regions
4.2 North America Colorectal Cancer Revenue and Growth Rate (2015-2020)
4.3 Europe Colorectal Cancer Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Colorectal Cancer Revenue and Growth Rate (2015-2020)
4.5 South America Colorectal Cancer Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Colorectal Cancer Revenue and Growth Rate (2015-2020)
5 North America Colorectal Cancer Revenue by Countries
5.1 North America Colorectal Cancer Revenue by Countries (2015-2020)
5.2 USA Colorectal Cancer Revenue and Growth Rate (2015-2020)
5.3 Canada Colorectal Cancer Revenue and Growth Rate (2015-2020)
5.4 Mexico Colorectal Cancer Revenue and Growth Rate (2015-2020)
6 Europe Colorectal Cancer Revenue by Countries
6.1 Europe Colorectal Cancer Revenue by Countries (2015-2020)
6.2 Germany Colorectal Cancer Revenue and Growth Rate (2015-2020)
6.3 UK Colorectal Cancer Revenue and Growth Rate (2015-2020)
6.4 France Colorectal Cancer Revenue and Growth Rate (2015-2020)
6.5 Russia Colorectal Cancer Revenue and Growth Rate (2015-2020)
6.6 Italy Colorectal Cancer Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Colorectal Cancer Revenue by Countries
7.1 Asia-Pacific Colorectal Cancer Revenue by Countries (2015-2020)
7.2 China Colorectal Cancer Revenue and Growth Rate (2015-2020)
7.3 Japan Colorectal Cancer Revenue and Growth Rate (2015-2020)
7.4 Korea Colorectal Cancer Revenue and Growth Rate (2015-2020)
7.5 India Colorectal Cancer Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Colorectal Cancer Revenue and Growth Rate (2015-2020)
8 South America Colorectal Cancer Revenue by Countries
8.1 South America Colorectal Cancer Revenue by Countries (2015-2020)
8.2 Brazil Colorectal Cancer Revenue and Growth Rate (2015-2020)
8.3 Argentina Colorectal Cancer Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Colorectal Cancer by Countries
9.1 Middle East & Africa Colorectal Cancer Revenue by Countries (2015-2020)
9.2 Saudi Arabia Colorectal Cancer Revenue and Growth Rate (2015-2020)
9.3 UAE Colorectal Cancer Revenue and Growth Rate (2015-2020)
9.4 Egypt Colorectal Cancer Revenue and Growth Rate (2015-2020)
9.5 South Africa Colorectal Cancer Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Colorectal Cancer Revenue and Market Share by Type (2015-2020)
10.2 Global Colorectal Cancer Market Forecast by Type (2019-2024)
10.3 Macroscopy Revenue Growth Rate (2015-2025)
10.4 Microscopy Revenue Growth Rate (2015-2025)
10.5 Immunochemistry Revenue Growth Rate (2015-2025)
10.6 Staging Revenue Growth Rate (2015-2025)
10.7 Tumor Budding Revenue Growth Rate (2015-2025)
11 Global Colorectal Cancer Market Segment by Application
11.1 Global Colorectal Cancer Revenue Market Share by Application (2015-2020)
11.2 Colorectal Cancer Market Forecast by Application (2019-2024)
11.3 Hospitals and Clicnics Revenue Growth (2015-2020)
11.4 Others Revenue Growth (2015-2020)
12 Global Colorectal Cancer Market Size Forecast (2021-2025)
12.1 Global Colorectal Cancer Market Size Forecast (2021-2025)
12.2 Global Colorectal Cancer Market Forecast by Regions (2021-2025)
12.3 North America Colorectal Cancer Revenue Market Forecast (2021-2025)
12.4 Europe Colorectal Cancer Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Colorectal Cancer Revenue Market Forecast (2021-2025)
12.6 South America Colorectal Cancer Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Colorectal Cancer Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Colorectal Cancer Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Colorectal Cancer by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Colorectal Cancer Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Colorectal Cancer Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Roche Corporate Information, Location and Competitors
Table 6. Roche Colorectal Cancer Major Business
Table 7. Roche Colorectal Cancer Total Revenue (USD Million) (2017-2018)
Table 8. Roche SWOT Analysis
Table 9. Roche Colorectal Cancer Product and Solutions
Table 10. Roche Colorectal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Mologen Corporate Information, Location and Competitors
Table 12. Mologen Colorectal Cancer Major Business
Table 13. Mologen Colorectal Cancer Total Revenue (USD Million) (2018-2019)
Table 14. Mologen SWOT Analysis
Table 15. Mologen Colorectal Cancer Product and Solutions
Table 16. Mologen Colorectal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Vaccinogen Corporate Information, Location and Competitors
Table 18. Vaccinogen Colorectal Cancer Major Business
Table 19. Vaccinogen Colorectal Cancer Total Revenue (USD Million) (2017-2018)
Table 20. Vaccinogen SWOT Analysis
Table 21. Vaccinogen Colorectal Cancer Product and Solutions
Table 22. Vaccinogen Colorectal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Debiopharm Corporate Information, Location and Competitors
Table 24. Debiopharm Colorectal Cancer Major Business
Table 25. Debiopharm Colorectal Cancer Total Revenue (USD Million) (2017-2018)
Table 26. Debiopharm SWOT Analysis
Table 27. Debiopharm Colorectal Cancer Product and Solutions
Table 28. Debiopharm Colorectal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Spectrum Pharmaceuticals Corporate Information, Location and Competitors
Table 30. Spectrum Pharmaceuticals Colorectal Cancer Major Business
Table 31. Spectrum Pharmaceuticals Colorectal Cancer Total Revenue (USD Million) (2017-2018)
Table 32. Spectrum Pharmaceuticals SWOT Analysis
Table 33. Spectrum Pharmaceuticals Colorectal Cancer Product and Solutions
Table 34. Spectrum Pharmaceuticals Colorectal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Merck Kgaa Corporate Information, Location and Competitors
Table 36. Merck Kgaa Colorectal Cancer Major Business
Table 37. Merck Kgaa Colorectal Cancer Total Revenue (USD Million) (2017-2018)
Table 38. Merck Kgaa SWOT Analysis
Table 39. Merck Kgaa Colorectal Cancer Product and Solutions
Table 40. Merck Kgaa Colorectal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Bayer Healthcare Corporate Information, Location and Competitors
Table 42. Bayer Healthcare Colorectal Cancer Major Business
Table 43. Bayer Healthcare Colorectal Cancer Total Revenue (USD Million) (2017-2018)
Table 44. Bayer Healthcare SWOT Analysis
Table 45. Bayer Healthcare Colorectal Cancer Product and Solutions
Table 46. Bayer Healthcare Colorectal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Keryx Corporate Information, Location and Competitors
Table 48. Keryx Colorectal Cancer Major Business
Table 49. Keryx Colorectal Cancer Total Revenue (USD Million) (2017-2018)
Table 50. Keryx SWOT Analysis
Table 51. Keryx Colorectal Cancer Product and Solutions
Table 52. Keryx Colorectal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Aeterna Zentaris Corporate Information, Location and Competitors
Table 54. Aeterna Zentaris Colorectal Cancer Major Business
Table 55. Aeterna Zentaris Colorectal Cancer Total Revenue (USD Million) (2017-2018)
Table 56. Aeterna Zentaris SWOT Analysis
Table 57. Aeterna Zentaris Colorectal Cancer Product and Solutions
Table 58. Aeterna Zentaris Colorectal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Amgen Corporate Information, Location and Competitors
Table 60. Amgen Colorectal Cancer Major Business
Table 61. Amgen Colorectal Cancer Total Revenue (USD Million) (2017-2018)
Table 62. Amgen SWOT Analysis
Table 63. Amgen Colorectal Cancer Product and Solutions
Table 64. Amgen Colorectal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Colorectal Cancer Revenue (Million USD) by Players (2015-2020)
Table 66. Global Colorectal Cancer Revenue Share by Players (2015-2020)
Table 67. Global Colorectal Cancer Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Colorectal Cancer Revenue Market Share by Regions (2015-2020)
Table 69. North America Colorectal Cancer Revenue by Countries (2015-2020)
Table 70. North America Colorectal Cancer Revenue Market Share by Countries (2015-2020)
Table 71. Europe Colorectal Cancer Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Colorectal Cancer Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Colorectal Cancer Revenue by Countries (2015-2020)
Table 74. South America Colorectal Cancer Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Colorectal Cancer Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Colorectal Cancer Revenue Market Share by Countries (2015-2020)
Table 77. Global Colorectal Cancer Revenue (Million USD) by Type (2015-2020)
Table 78. Global Colorectal Cancer Revenue Share by Type (2015-2020)
Table 79. Global Colorectal Cancer Revenue Forecast by Type (2021-2025)
Table 80. Global Colorectal Cancer Revenue by Application (2015-2020)
Table 81. Global Colorectal Cancer Revenue Share by Application (2015-2020)
Table 82. Global Colorectal Cancer Revenue Forecast by Application (2021-2025)
Table 83. Global Colorectal Cancer Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Colorectal Cancer Picture
Figure 2. Global Colorectal Cancer Revenue Market Share by Type in 2019
Figure 3. Macroscopy Picture
Figure 4. Microscopy Picture
Figure 5. Immunochemistry Picture
Figure 6. Staging Picture
Figure 7. Tumor Budding Picture
Figure 8. Colorectal Cancer Revenue Market Share by Application in 2019
Figure 9. Hospitals and Clicnics Picture
Figure 10. Others Picture
Figure 11. Global Colorectal Cancer Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Colorectal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Colorectal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Colorectal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Colorectal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Colorectal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Colorectal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Colorectal Cancer Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Colorectal Cancer Revenue Market Share in 2019
Figure 20. Global Top 10 Players Colorectal Cancer Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Colorectal Cancer Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Colorectal Cancer Revenue Market Share by Regions (2015-2020)
Figure 24. Global Colorectal Cancer Revenue Market Share by Regions in 2018
Figure 25. North America Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 26. Europe Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 28. South America Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 30. North America Colorectal Cancer Revenue Market Share by Countries (2015-2020)
Figure 31. North America Colorectal Cancer Revenue Market Share by Countries in 2019
Figure 32. USA Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 33. Canada Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 35. Europe Colorectal Cancer Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Colorectal Cancer Revenue Market Share by Countries in 2019
Figure 37. Germany Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 38. UK Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 39. France Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 40. Russia Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 41. Italy Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Colorectal Cancer Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Colorectal Cancer Revenue Market Share by Countries in 2019
Figure 44. China Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 45. Japan Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 46. Korea Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 47. India Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 49. South America Colorectal Cancer Revenue Market Share by Countries (2015-2020)
Figure 50. South America Colorectal Cancer Revenue Market Share by Countries in 2019
Figure 51. Brazil Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Colorectal Cancer Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Colorectal Cancer Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 56. UAE Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Colorectal Cancer Revenue and Growth Rate (2015-2020)
Figure 59. Global Colorectal Cancer Revenue Share by Type (2015-2020)
Figure 60. Global Colorectal Cancer Revenue Share by Type in 2019
Figure 61. Global Colorectal Cancer Market Share Forecast by Type (2021-2025)
Figure 62. Global Macroscopy Revenue Growth Rate (2015-2020)
Figure 63. Global Microscopy Revenue Growth Rate (2015-2020)
Figure 64. Global Immunochemistry Revenue Growth Rate (2015-2020)
Figure 65. Global Staging Revenue Growth Rate (2015-2020)
Figure 66. Global Tumor Budding Revenue Growth Rate (2015-2020)
Figure 67. Global Colorectal Cancer Revenue Share by Application (2015-2020)
Figure 68. Global Colorectal Cancer Revenue Share by Application in 2019
Figure 69. Global Colorectal Cancer Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospitals and Clicnics Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Colorectal Cancer Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Colorectal Cancer Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Colorectal Cancer Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Colorectal Cancer Revenue Market Forecast (2021-2025)
Figure 76. Europe Colorectal Cancer Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Colorectal Cancer Revenue Market Forecast (2021-2025)
Figure 78. South America Colorectal Cancer Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Colorectal Cancer Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
転移性大腸がん手術の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Metastatic Colorectal Cancer Surgery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metastat…- 大腸がん診断＆治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Colorectal Cancer Diagnosis and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …
- 肛門がん及び結腸直腸がんの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Anal and Colorectal Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anal and Colorecta…
- 固形腫瘍治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Solid Tumor Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.1% in the forecast period of 2020 to 2025 and will expected to reach USD 156810 million by 2025, from USD 114670 million in 2019. The Solid Tumor…
- がん画像システムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cancer Imaging System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cancer Imaging System m…